In the BioHarmony Drug Report Database

"Preview" Icon

Calaspargase pegol-mknl

Asparlas (calaspargase pegol) is an enzyme pharmaceutical. Calaspargase pegol was first approved as Asparlas on 2018-12-20. It is used to treat precursor cell lymphoblastic leukemia-lymphoma in the USA.

 

Trade Name

 

Asparlas
 

Common Name

 

calaspargase pegol
 

ChEMBL ID

 

CHEMBL2108728
 

Indication

 

precursor cell lymphoblastic leukemia-lymphoma
 

Drug Class

 

Enzymes; PEGylated compounds

Image (chem structure or protein)

Calaspargase pegol-mknl structure rendering